DBCO-tag peptide P1
DBCO-tag peptide P1 is a cysteine-containing peptide tag. DBCO-tag peptide P1 selectively reacts with dibenzocyclooctyne (DBCO) to yield stable dibenzocyclooctenyl thioethers. DBCO-tag peptide P1 enables site-selective mEGFP labeling and antibody (such as Trastuzumab ) labelling without impairing the protein binding function. DBCO-tag peptide P1 can be used for ADC synthesis and mEGFP labeling research[1].
Product Specifications
UNSPSC
12352209
Target
Biochemical Assay Reagents; Drug-Linker Conjugates for ADC
Related Pathways
Antibody-drug Conjugate/ADC Related; Others
Field of Research
Others
Smiles
Molecular Formula
C48H62N8O10S
Molecular Weight
943.12
References & Citations
[1]Zhang C, et al. Site-Selective Cysteine-Cyclooctyne Conjugation. Angew Chem Int Ed Engl. 2018 May 28;57 (22) :6459-6463.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF488A conjugate, 0.1mg/mL
Ferritin, Light Chain (FTL) (Microglia Marker) (FTL/1387), CF647 conjugate, 0.1mg/mL
CD31 / PECAM-1 (C31.10), CF660R conjugate, 0.1mg/mL
